Mandate

Vinge has advised VEF AB (publ) in connection with the listing of the company’s ordinary shares on Nasdaq Stockholm’s Main Market

Vinge has advised VEF AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s Main Market. The prospectus was published on 30 May 2022 and the trading on Nasdaq Stockholm commenced on 1 June 2022.

VEF is an investment company that invests in growth stage private fintech companies. VEF focuses on scale emerging markets and invests across all areas of financial services inclusive of payments, credit, mobile money and wealth advisors.

Vinge’s team has primarily consisted of Jesper Schönbeck, Joel Wahlberg, Emma Brolund, Anna Svensson and Johannes Akyol (Capital Markets and Public M&A) and Victor Ericsson and Emelie Svanberg (Corporate Tax).

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025